Heat shock proteins HSPB8 and DNAJC5B have HCV antiviral activity

Ana Claudia Silva Braga1, Bruno Moreira Carneiro1,2, Mariana Nogueira Batista1

  • 1Laboratório de Estudos Genômicos, UNESP/IBILCE, São José do Rio Preto, São Paulo, Brazil.

Plos One
|November 29, 2017
PubMed

Insights

Heat shock proteins HSPB8 and DNAJC5B inhibit hepatitis C virus (HCV) replication. Upregulating HSPB8 reduces HCV replication, while silencing it increases viral load, suggesting a protective role against HCV infection.

Area of Science:

  • Hepatology
  • Virology
  • Molecular Biology

Background:

  • Hepatitis C virus (HCV) infection affects millions globally, with viral replication involving host cellular proteins.
  • Heat shock proteins (HSPs) exhibit altered expression during HCV infection and some directly interact with viral proteins.

Purpose of the Study:

  • To investigate the role of heat shock proteins (HSPs) in hepatitis C virus (HCV) replication.
  • To identify specific HSPs that influence HCV replication and understand their interaction mechanisms.

Main Methods:

  • Differential expression analysis of 84 HSPs and chaperones using qPCR array in HCV-infected vs. uninfected cells.
  • Validation of differentially expressed genes via real-time PCR in three distinct HCV models (SGR-JFH-1, JFH-1, S52).
  • Gene silencing and overexpression experiments for HSPB8 and DNAJC5B to assess their impact on viral replication; co-immunoprecipitation to study protein interactions.

Main Results:

  • HSPB8 and DNAJC5B expression increased in all tested HCV models.
  • Silencing HSPB8 or DNAJC5B enhanced HCV replication, whereas their overexpression reduced it.
  • HCV NS4B protein was found to directly interact with HSPB8.

Conclusions:

  • HSPB8 and DNAJC5B function as intracellular factors that inhibit hepatitis C virus replication, particularly for genotype 3.
  • The interaction between HCV NS4B and HSPB8 provides insight into the host-pathogen mechanisms during HCV infection.